Systemic administration of a novel development candidate, MTL-CEBPA, up-regulates the liver-enriched transcription factor C/EBP-alpha and reverses CCl4-induced liver failure in vivo.

Authors
Publication date
22 June 2017
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    National Taiwan University Repository

    redirect
    oaioai:140.112.114.62:246246/2799...
    Last time updated on 20/05/2019